Sharif S. Khan

Hematology
104 Innovation Drive
Suite 2100
Greenville, SC 29607

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.

Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.

Journal: Leukemia & lymphoma
Published: May 03, 2022
Showing 1-1 of 1

Last Updated: 09/26/2026